Valeant to acquire PreCision Dermatology

3 February 2014 - Deborah Wilkes


Valeant Pharmaceuticals International is boosting its skincare business by acquiring US-based PreCision Dermatology in a deal worth around US$500 million.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: